Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Interferon Alpha and Isotretinoin in Patients With T-Cell Malignancies

NCT00038376 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00038376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00038376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Interferon Alpha and Isotretinoin in Patients With T-Cell Malignancies
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
May 8, 1990
Completion date
June 30, 2005
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic neoplasms, lymphoma, t-cell, mycosis fungoides